Effects of synthetic 2, 4, 6-trihydroxy-3-geranylacetophenone upon TNF-α-induced epithelial dysfunction

Asthma is characterized by activation of Th-2 (T-helper-2)-type T-cell, and patients clinically presented with breathlessness, wheezing, cough, and chest tightness. Current treatments for asthma is just symptomatic relieve during acute exacerbation and prevent from attacks using controllers. All thi...

Full description

Bibliographic Details
Main Author: Sim, Tee Yee
Format: Thesis
Language:English
Published: 2016
Subjects:
Online Access:http://psasir.upm.edu.my/id/eprint/76277/1/FPSK%28M%29%202016%2081%20-%20IR.pdf
_version_ 1796980031019286528
author Sim, Tee Yee
author_facet Sim, Tee Yee
author_sort Sim, Tee Yee
collection UPM
description Asthma is characterized by activation of Th-2 (T-helper-2)-type T-cell, and patients clinically presented with breathlessness, wheezing, cough, and chest tightness. Current treatments for asthma is just symptomatic relieve during acute exacerbation and prevent from attacks using controllers. All this treatment is not actually treating the new pathogenesis of this disease which is targeting the airway epithelium barrier. Studies shown 5-10% of asthma patient does not have any responds towards usual corticosteroid treatment, therefore there is a need to develop a new drug which can work on the actual pathogenesis of asthma. Airway epithelium plays a critical role in inflammatory reactions by acting as a barrier to external environment, producing chemokines and expressing cell-surface adhesion molecules for recruitment of effector cells. Preliminary studies show that 2,4,6–trihydroxy–3– geranylacetophenone (tHGA) inhibits the synthesis of cysteinyl leukotrienes in activated macrophages via inhibition of 5-lipoxygenase (5-LO) enzymatic activity. This study aimed to determine inhibitory effect of tHGA on adhesion molecule, epithelium hyperpermeability, tight junction barrier and pro-inflammatory signaling pathways that are involved. A549 cell was induced with tumor necrosis factor alpha (TNF-α) 10ng/mL and co-treated with different concentration of tHGA (50μM, 12μM, 3μM) and Dexamethsone 10 μM act as drug control group. Epithelium hyperpermeability was measured by fluorescein isothiocyanate–dextran (FITC-Dextran) permeability assay and trans-epithelial electrical resistance (TEER). Adhesion assay and transepithelium migration assay was performed by using A549 cells and U937 cells. Enzyme-linked immunosorbent assay (ELISA) was used to determine soluble intercellular adhesion molecule-1 (sICAM-1) level and monocyte chemoattractant protein-1 (MCP-1) levels. Membrane expression of tight junction complexes proteins (Zonula occluden 1, occludin, and E-cadherin) was investigated under immunofluorescence, gene expression and protein expression studies. Phosphorylation of mitogen-activated protein kinases (MAPK) and nuclear factor kappa-light-chain-enhancer of activated B cells (NFκB) pathway was studied. The data obtained concluded that 50 μM tHGA had 32.10 ± 8.03% significantly suppressed leukocytes moving across epithelium. tHGA had reduced adhesion molecule expression by 43.45 ± 0.16%, therefore inhibit adhesion of monocytes to tumor necrosis factor TNF-α induced epithelium (43 ± 5.77%) and reduce transepithelium migration. tHGA is able to increase TEER, reduce epithelium hyperpermeability by 41± 6.35%. tHGA enhance airway barrier integrity through redistribution of TJ proteins (ZO-1, occludin) and AJ protein (E-cadherin) and NF-κB pathway and MAPK pathway be could involved in this process.
first_indexed 2024-03-06T10:17:30Z
format Thesis
id upm.eprints-76277
institution Universiti Putra Malaysia
language English
last_indexed 2024-03-06T10:17:30Z
publishDate 2016
record_format dspace
spelling upm.eprints-762772020-01-21T00:47:35Z http://psasir.upm.edu.my/id/eprint/76277/ Effects of synthetic 2, 4, 6-trihydroxy-3-geranylacetophenone upon TNF-α-induced epithelial dysfunction Sim, Tee Yee Asthma is characterized by activation of Th-2 (T-helper-2)-type T-cell, and patients clinically presented with breathlessness, wheezing, cough, and chest tightness. Current treatments for asthma is just symptomatic relieve during acute exacerbation and prevent from attacks using controllers. All this treatment is not actually treating the new pathogenesis of this disease which is targeting the airway epithelium barrier. Studies shown 5-10% of asthma patient does not have any responds towards usual corticosteroid treatment, therefore there is a need to develop a new drug which can work on the actual pathogenesis of asthma. Airway epithelium plays a critical role in inflammatory reactions by acting as a barrier to external environment, producing chemokines and expressing cell-surface adhesion molecules for recruitment of effector cells. Preliminary studies show that 2,4,6–trihydroxy–3– geranylacetophenone (tHGA) inhibits the synthesis of cysteinyl leukotrienes in activated macrophages via inhibition of 5-lipoxygenase (5-LO) enzymatic activity. This study aimed to determine inhibitory effect of tHGA on adhesion molecule, epithelium hyperpermeability, tight junction barrier and pro-inflammatory signaling pathways that are involved. A549 cell was induced with tumor necrosis factor alpha (TNF-α) 10ng/mL and co-treated with different concentration of tHGA (50μM, 12μM, 3μM) and Dexamethsone 10 μM act as drug control group. Epithelium hyperpermeability was measured by fluorescein isothiocyanate–dextran (FITC-Dextran) permeability assay and trans-epithelial electrical resistance (TEER). Adhesion assay and transepithelium migration assay was performed by using A549 cells and U937 cells. Enzyme-linked immunosorbent assay (ELISA) was used to determine soluble intercellular adhesion molecule-1 (sICAM-1) level and monocyte chemoattractant protein-1 (MCP-1) levels. Membrane expression of tight junction complexes proteins (Zonula occluden 1, occludin, and E-cadherin) was investigated under immunofluorescence, gene expression and protein expression studies. Phosphorylation of mitogen-activated protein kinases (MAPK) and nuclear factor kappa-light-chain-enhancer of activated B cells (NFκB) pathway was studied. The data obtained concluded that 50 μM tHGA had 32.10 ± 8.03% significantly suppressed leukocytes moving across epithelium. tHGA had reduced adhesion molecule expression by 43.45 ± 0.16%, therefore inhibit adhesion of monocytes to tumor necrosis factor TNF-α induced epithelium (43 ± 5.77%) and reduce transepithelium migration. tHGA is able to increase TEER, reduce epithelium hyperpermeability by 41± 6.35%. tHGA enhance airway barrier integrity through redistribution of TJ proteins (ZO-1, occludin) and AJ protein (E-cadherin) and NF-κB pathway and MAPK pathway be could involved in this process. 2016-02 Thesis NonPeerReviewed text en http://psasir.upm.edu.my/id/eprint/76277/1/FPSK%28M%29%202016%2081%20-%20IR.pdf Sim, Tee Yee (2016) Effects of synthetic 2, 4, 6-trihydroxy-3-geranylacetophenone upon TNF-α-induced epithelial dysfunction. Masters thesis, Universiti Putra Malaysia. Asthma - therapy Epithelial Cells Asthma
spellingShingle Asthma - therapy
Epithelial Cells
Asthma
Sim, Tee Yee
Effects of synthetic 2, 4, 6-trihydroxy-3-geranylacetophenone upon TNF-α-induced epithelial dysfunction
title Effects of synthetic 2, 4, 6-trihydroxy-3-geranylacetophenone upon TNF-α-induced epithelial dysfunction
title_full Effects of synthetic 2, 4, 6-trihydroxy-3-geranylacetophenone upon TNF-α-induced epithelial dysfunction
title_fullStr Effects of synthetic 2, 4, 6-trihydroxy-3-geranylacetophenone upon TNF-α-induced epithelial dysfunction
title_full_unstemmed Effects of synthetic 2, 4, 6-trihydroxy-3-geranylacetophenone upon TNF-α-induced epithelial dysfunction
title_short Effects of synthetic 2, 4, 6-trihydroxy-3-geranylacetophenone upon TNF-α-induced epithelial dysfunction
title_sort effects of synthetic 2 4 6 trihydroxy 3 geranylacetophenone upon tnf α induced epithelial dysfunction
topic Asthma - therapy
Epithelial Cells
Asthma
url http://psasir.upm.edu.my/id/eprint/76277/1/FPSK%28M%29%202016%2081%20-%20IR.pdf
work_keys_str_mv AT simteeyee effectsofsynthetic246trihydroxy3geranylacetophenoneupontnfainducedepithelialdysfunction